Epigral Outperforms Specialty Chemicals Sector Amid Broader Market Fluctuations

Epigral, a midcap player in the specialty chemicals industry, has shown significant activity today, gaining 7.38% on July 30, 2025. This performance marks a notable outperformance against its sector, exceeding sector gains by 5.04%. Over the past two days, Epigral has demonstrated a strong upward trend, accumulating a total return of 13.71%. The stock reached an intraday high of Rs 2071.9, reflecting a 5.9% increase during the trading session. Notably, Epigral is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a robust short- to long-term performance. In the broader market context, the Sensex opened higher at 81,594.52, gaining 256.57 points, but is currently trading slightly lower at 81,380.05. Despite the Sensex experiencing a three-week decline of 1.36%, small-cap stocks are leading the market today, with the BSE Small Cap index up by 0.2%. Epigral's performance metrics over various time frames further illustrate its resilience, with a 1-year return of 20.00% compared to the Sensex's slight decline of 0.05%.